Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.
about
Serum folate levels after UVA exposure: a two-group parallel randomised controlled trialCollecting a set of psoriasis family material through a patient organisation; clinical characterisation and presence of additional disorders.Psoriasis: classical and emerging comorbiditiesDiet and psoriasis: experimental data and clinical evidence.Death from psoriasis: representative US data.Activation of PPARbeta/delta causes a psoriasis-like skin disease in vivo.The relationship between different dimensions of alcohol use and the burden of disease-an update.Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.Trends in incidence of adult-onset psoriasis over three decades: a population-based study.Psoriasis and its managementDiagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.Psoriasis and vascular disease-risk factors and outcomes: a systematic review of the literatureThe importance of disease associations and concomitant therapy for the long-term management of psoriasis patientsEnvironmental Basis of Autoimmunity.Summary of the 2014 Alcohol and Immunology Research Interest Group (AIRIG) meetingDisease severity and therapy as predictors of cardiovascular risk in psoriasis: a population-based cohort study.Smoking and risk of incident psoriasis among women and men in the United States: a combined analysis.The comorbid state of psoriasis patients in a university dermatology practice.Quality of life and psychosocial aspects in Greek patients with psoriasis: a cross-sectional study.Risk and predictors of cardiovascular disease in psoriasis: a population-based study.Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.Treatment of severe psoriasis with infliximab.Cardiometabolic risk in psoriasis: differential effects of biologic agents.Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden'I should have taken that further' - missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study.Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseasesPsoriasis comorbidities.Stress and quality of life in psoriasis: an update.Alcohol, psoriasis, liver disease, and anti-psoriasis drugs.Alcohol and psoriasis: sobering thoughts.Psoriasis and psycho-dermatology.Pediatric Psoriasis Comorbidity Screening Guidelines.Diagnosing liver fibrosis: a narrative review of current literature for dermatologists.Psoriasis as an Independent Risk Factor for Cardiovascular Disease: An Epidemiologic Analysis Using a National Database.Influence of psoriasis on circulatory system function assessed in echocardiography.'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well® patient materials mixed-methods feasibility study.Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.'In someone's clinic but not in mine'--clinicians' views of supporting lifestyle behaviour change in patients with psoriasis: a qualitative interview study.
P2860
Q24796194-43D9367F-5FD2-4A3C-92E8-16C4DAC6D719Q24816472-06A4E6DE-4D14-44AF-8650-265E7664F91AQ28088340-2942E1C3-95CA-485F-84F5-BFAA6A6E4E46Q31006990-5D167DBE-15D9-4680-AFBF-C9071A0B6539Q31075515-B557E0FD-231A-4BE3-90CA-77AAF44A0A74Q33543078-F2455F94-9B99-42A0-9D9F-9255AC36B323Q33698181-E4CC8EC5-6783-4A42-98B3-578B81199941Q33858767-AC7EE95D-76A0-4C8B-9133-DFC2EC58E689Q34253312-0297F167-0789-4FD9-9728-38419E480427Q34527982-F7A1E576-8EC7-4141-B2B2-7E1047576D11Q34997840-68182D8C-B1AA-4A6F-B6C8-7F1207879929Q35109287-E4EBE32E-DE03-47CF-80DD-435A99367EBAQ35168945-111BEE9B-BD09-4472-AEC4-5AE116572017Q35230117-A2E4FA29-7816-4B94-9B21-45229D7BA799Q35638839-B16142A5-616B-430F-8869-A00D342E4542Q35828288-B6099D85-2E5F-4C12-8F18-D9BF6194B5A3Q35854188-000AEF72-6E78-44C8-ADCC-899594FE0AA0Q35896544-25A341D9-B44C-48A5-B9D8-36F244BFF969Q36374594-BBD40756-6252-44AB-9316-0EF22506223BQ36398293-98EADB49-F86E-449D-8923-CFCEC267D00EQ36515160-DECE6D1D-6E4B-4928-96FA-867C2FD82E94Q36879686-B01D44B3-0AC6-41C6-9A17-1FC913053285Q37027264-3FF7D2B4-7E27-4A04-871B-CABE67E2ECCFQ37098135-A03F5D8C-9612-440F-A071-EB854436B4E2Q37145684-6CE3BAD3-95D2-478F-BEDA-2BED0FD28C0CQ37222674-7FED2B78-E6D0-4FC7-83E4-DBEB42F693D2Q37316423-B1F47042-4EAC-4472-8C63-FA2F08BEF64CQ37404893-D25D3D8E-51B6-4BC3-9924-9CEA417FF907Q37607422-FDA29F01-D811-4D98-8C76-33C6A1B661FCQ37893691-A72EE6B8-0C69-44A7-88FC-BD06A01EE14FQ37946497-C712B4B5-DB3B-42FC-9723-C3A8CC88EE10Q38164129-4FC5CE43-B3A4-4AE4-8522-9DE6E005CDABQ38443811-CB98CB8D-8A31-4B95-A43C-4A8CEFA8690FQ38682771-6C83BF5E-EADF-40E1-ABB6-B46B06A9DB6FQ38780434-A3E0CC5C-F513-4690-B950-0D41C0E78733Q40597678-5E761769-97AE-4224-B4EC-8BEE6CA5E642Q41631142-BD34F948-8D65-48E7-AEE4-E29D953672C0Q42703641-60E1E316-F5D6-4760-BF71-EA3D6B45EE49Q43477625-60AC94F0-A197-435B-B649-1C9F79ABB4E1Q43742824-5D12CBBA-C03F-4F10-A758-9B7C2A5A1651
P2860
Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Excess mortality related to al ...... eated patients with psoriasis.
@en
Excess mortality related to al ...... eated patients with psoriasis.
@nl
type
label
Excess mortality related to al ...... eated patients with psoriasis.
@en
Excess mortality related to al ...... eated patients with psoriasis.
@nl
prefLabel
Excess mortality related to al ...... eated patients with psoriasis.
@en
Excess mortality related to al ...... eated patients with psoriasis.
@nl
P2093
P1433
P1476
Excess mortality related to al ...... eated patients with psoriasis.
@en
P2093
Karvonen J
Poikolainen K
P304
P356
10.1001/ARCHDERM.135.12.1490
P577
1999-12-01T00:00:00Z